These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2614692)

  • 1. Power analyses of moment analysis parameter in bioequivalence tests.
    Kaniwa N; Ogata H; Aoyagi N; Takeda Y; Uchiyama M
    J Pharm Sci; 1989 Dec; 78(12):1020-4. PubMed ID: 2614692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
    Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
    J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.
    Lacey LF; Keene ON; Duquesnoy C; Bye A
    J Pharm Sci; 1994 Feb; 83(2):212-5. PubMed ID: 8169791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and bioequivalence of veterinary drug dosage forms, with particular reference to horses: an overview.
    Baggot JD
    J Vet Pharmacol Ther; 1992 Jun; 15(2):160-73. PubMed ID: 1433478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop.
    Luckow V; Della Paschoa O
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel multivariate approach for estimating the degree of similarity in bioavailability between two pharmaceutical products.
    Hsu HC; Lu HL; Chan KK
    J Pharm Sci; 1995 Jun; 84(6):768-72. PubMed ID: 7562420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.
    Schall R; Luus HG; Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):323-8. PubMed ID: 7952792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of absorption rates in bioequivalence studies of immediate release drug formulations.
    Schall R; Luus HG
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):153-9. PubMed ID: 1592542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of indirect metrics for assessing "rate" in bioequivalence studies--moving the "goalposts" or changing the "game".
    Rostami-Hodjegan A; Jackson PR; Tucker GT
    J Pharm Sci; 1994 Nov; 83(11):1554-7. PubMed ID: 7891273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of steady-state bioequivalence relationships using single dose data I-linear kinetics.
    Jackson AJ
    Biopharm Drug Dispos; 1987; 8(5):483-96. PubMed ID: 3663884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tmax: an unconfounded metric for rate of absorption in single dose bioequivalence studies.
    Basson RP; Cerimele BJ; DeSante KA; Howey DC
    Pharm Res; 1996 Feb; 13(2):324-8. PubMed ID: 8932457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Average parameters as a trend to reduce the residual variability in bioequivalence trials.
    Fagiolino P; Vazquez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):153-9. PubMed ID: 9725474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of the MANOVA of statistical moments in bioequivalence trials of drugs with slow elimination rate: a study with spironolactone.
    Concheiro A; Llabres M; Martinez R; Vila JL
    Biopharm Drug Dispos; 1986; 7(3):253-64. PubMed ID: 3730525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the theory of the optimal sampling scheme for bioequivalence studies].
    Tod M; Petitjean O; Nicolas P
    Therapie; 1993; 48(1):7-13. PubMed ID: 8356559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence: performance of several measures of extent of absorption.
    Bois FY; Tozer TN; Hauck WW; Chen ML; Patnaik R; Williams RL
    Pharm Res; 1994 May; 11(5):715-22. PubMed ID: 8058642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of the peak concentration following single and repeated drug administrations in investigations of bioavailability and bioequivalence.
    Zha J; Endrenyi L
    J Biopharm Stat; 1997 Mar; 7(1):191-204. PubMed ID: 9056598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of two azithromycin formulations in healthy subjects.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A
    Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and Bioequiavailability of Asparaginase in Asparaginase Nanospheres].
    Yan ZJ; Li WY; Hu XY; Deng X; Wang SL; Zhang JQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):411-5. PubMed ID: 27468491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.